Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Smiths News announces Richard Clay as new finance chief

(Sharecast News) - Smiths News announced the appointment of Richard Clay as its next chief financial officer on Thursday, with his start date expected no later than 30 January 2026. He would also join the board as a director upon appointment, succeeding Paul Baker, who was stepping down to join a private business in another sector.

The London-listed press distributor said Clay would bring extensive experience in senior finance and strategy roles across financial and support services.

He is currently interim chief financial officer and UK and Ireland group finance director at mobility firm Zigup, formerly known as Redde Northgate.

Since joining Zigup in 2018, Clay has held several roles including head of group strategy, financial planning and analysis, and investor relations.

Earlier in his career, he held a number of finance director and chief financial officer positions at Barclays, focussed on business and corporate banking.

He started his career at Deloitte, spending eight years in corporate finance advising on strategic change, and is a qualified accountant.

"Richard joins at an exciting time for the business as we continue to capitalise on our first-class newspaper and magazine distribution capabilities and to further diversify across the specialist distribution market," said chairman David Blackwood.

Blackwood added that Clay's financial, strategic and commercial expertise would help drive growth across both new and existing revenue streams.

At 1112 BST, shares in Smiths News were down 0.32% at 55.82p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.